Exploring computer learning to predict Parkinson's disease progression, how the immune system becomes exhausted in HIV, and how to offer patients better diabetes care.

The latest on sustainability in fashion, studying what curbed the spread of COVID-19 best, and working with patients toward better assistive devices.

From detective shows to decoding genetic data - how a Jefferson alum found her way to the world of computational research.

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that often fails to respond to treatments. Researchers at Jefferson Health's Sidney Kimmel Cancer Center (SKCC) have developed a novel therapeutic strategy that could revolutionize its treatment – and are challenging scientific beliefs in the process.

Understanding generational trauma and how therapists can be trained to help individuals cope.

Read the latest on the barriers to life after prison, a new treatment avenue for visceral pain, and how older people were cared for during the global pandemic

Jefferson’s CEO Joseph G. Cacchione, MD is pleased to announce that John P. Mordach, has been named Executive Vice President and Chief Financial Officer of Jefferson, which consists of Thomas Jefferson University, Jefferson Health and Health Partners Plans. Effective March 20, 2023, Mordach will join the organization from Duke University Health System (DUHS) where he served as Senior Vice President, CFO and Treasurer for the $4.5 billion academic health system since 2020. 

With a projected 2.5 billion more people living in cities by 2050, the need has never been greater.

Researchers discover a potential therapeutic avenue against an aggressive form of prostate cancer. 

New research into making asthma and COPD medication more potent could also improve how long they work in patients who need frequent doses.